BRPI0921907A2 - Vetor de transferência para inserir um gene em um local genético de uma seqüência de baculovírus, métodos para produzir um bacmid recombinante, um baculovírus recombinante, e, uma ou mais proteínas, bacmid recombinante, baculovírus recombinante, e, célula. - Google Patents

Vetor de transferência para inserir um gene em um local genético de uma seqüência de baculovírus, métodos para produzir um bacmid recombinante, um baculovírus recombinante, e, uma ou mais proteínas, bacmid recombinante, baculovírus recombinante, e, célula.

Info

Publication number
BRPI0921907A2
BRPI0921907A2 BRPI0921907-2A BRPI0921907A BRPI0921907A2 BR PI0921907 A2 BRPI0921907 A2 BR PI0921907A2 BR PI0921907 A BRPI0921907 A BR PI0921907A BR PI0921907 A2 BRPI0921907 A2 BR PI0921907A2
Authority
BR
Brazil
Prior art keywords
recombinant
baculovirus
bacmid
gene
proteins
Prior art date
Application number
BRPI0921907-2A
Other languages
English (en)
Inventor
Polly Roy
Robert James Noad
Original Assignee
London School Of Hygiene & Tropical Medicine
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by London School Of Hygiene & Tropical Medicine filed Critical London School Of Hygiene & Tropical Medicine
Publication of BRPI0921907A2 publication Critical patent/BRPI0921907A2/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/14011—Baculoviridae
    • C12N2710/14021—Viruses as such, e.g. new isolates, mutants or their genomic sequences
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/14011—Baculoviridae
    • C12N2710/14041—Use of virus, viral particle or viral elements as a vector
    • C12N2710/14043—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vectore
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/14011—Baculoviridae
    • C12N2710/14051—Methods of production or purification of viral material
    • C12N2710/14052—Methods of production or purification of viral material relating to complementing cells and packaging systems for producing virus or viral particles
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/14011—Baculoviridae
    • C12N2710/14111—Nucleopolyhedrovirus, e.g. autographa californica nucleopolyhedrovirus
    • C12N2710/14121—Viruses as such, e.g. new isolates, mutants or their genomic sequences
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/14011—Baculoviridae
    • C12N2710/14111—Nucleopolyhedrovirus, e.g. autographa californica nucleopolyhedrovirus
    • C12N2710/14141—Use of virus, viral particle or viral elements as a vector
    • C12N2710/14143—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2800/00—Nucleic acids vectors
    • C12N2800/30—Vector systems comprising sequences for excision in presence of a recombinase, e.g. loxP or FRT

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Virology (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
BRPI0921907-2A 2008-11-11 2009-11-11 Vetor de transferência para inserir um gene em um local genético de uma seqüência de baculovírus, métodos para produzir um bacmid recombinante, um baculovírus recombinante, e, uma ou mais proteínas, bacmid recombinante, baculovírus recombinante, e, célula. BRPI0921907A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0820631.0A GB0820631D0 (en) 2008-11-11 2008-11-11 Vectors
PCT/GB2009/002647 WO2010055292A2 (en) 2008-11-11 2009-11-11 Vectors

Publications (1)

Publication Number Publication Date
BRPI0921907A2 true BRPI0921907A2 (pt) 2015-08-25

Family

ID=40139744

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0921907-2A BRPI0921907A2 (pt) 2008-11-11 2009-11-11 Vetor de transferência para inserir um gene em um local genético de uma seqüência de baculovírus, métodos para produzir um bacmid recombinante, um baculovírus recombinante, e, uma ou mais proteínas, bacmid recombinante, baculovírus recombinante, e, célula.

Country Status (20)

Country Link
US (2) US9212374B2 (pt)
EP (1) EP2358883B1 (pt)
JP (2) JP5986381B2 (pt)
KR (1) KR20110089420A (pt)
CN (2) CN102245777B (pt)
AU (1) AU2009315471B2 (pt)
BR (1) BRPI0921907A2 (pt)
CA (1) CA2740714A1 (pt)
CL (2) CL2011001056A1 (pt)
CO (1) CO6420360A2 (pt)
ES (1) ES2616855T3 (pt)
GB (1) GB0820631D0 (pt)
MX (2) MX340956B (pt)
MY (1) MY178947A (pt)
PH (1) PH12014501252A1 (pt)
RU (2) RU2569183C2 (pt)
SG (1) SG10201509570TA (pt)
UA (1) UA106733C2 (pt)
WO (1) WO2010055292A2 (pt)
ZA (2) ZA201103286B (pt)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0820631D0 (en) 2008-11-11 2008-12-17 London School Hygiene & Tropical Medicine Vectors
CA3035048C (en) 2010-12-23 2021-05-04 Mark Deem System for mitral valve repair and replacement
FR2978456B1 (fr) 2011-07-27 2015-02-20 Genethon Systeme baculoviral pour l'expression d'un vecteur de therapie genique
GB201309132D0 (en) * 2013-05-21 2013-07-03 Biosyntia Aps Regulatable gene expression
WO2016204644A1 (ru) * 2015-06-19 2016-12-22 Общество С Ограниченной Ответственностью "Панацела Лабс" Способ производства препарата на основе нереплицирующегося вирусного вектора, экспрессирующего ген человеческого toll-подобного рецептора и ген модифицированного белка флагеллина
FR3054841B1 (fr) * 2016-08-05 2021-01-29 Centre Nat Rech Scient Systeme d'expression baculovirus
NZ762100A (en) 2017-08-09 2025-12-19 Bioverativ Therapeutics Inc Nucleic acid molecules and uses thereof
FR3072686B1 (fr) * 2017-10-25 2021-10-22 Centre Nat Rech Scient Systeme d'expression baculovirus
EP3833766A1 (en) 2018-08-09 2021-06-16 Bioverativ Therapeutics Inc. Nucleic acid molecules and uses thereof for non-viral gene therapy
CN109609552B (zh) * 2018-12-28 2020-04-14 中国科学院武汉物理与数学研究所 重组腺相关病毒的制备方法、系统及重组杆粒
CN114369624B (zh) * 2021-12-30 2023-07-14 华南农业大学 一种降低病毒感染导致的昆虫细胞凋亡的方法
CN118956967A (zh) * 2024-04-17 2024-11-15 和元生物技术（上海）股份有限公司 核酸分子、包含其的重组杆状病毒及其应用

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1257184B (it) * 1992-12-22 1996-01-10 Applied Research Systems Preparato ad attivita' antinfiammatoria, anticoagulante e antitumorale
JP2001501824A (ja) * 1996-10-01 2001-02-13 ユニバーシティー オブ ジョージア リサーチ ファウンデーション，インコーポレイテッド 昆虫特異的ダニ毒素遺伝子を発現する生物学的昆虫防除剤、方法および組成物
US6054312A (en) * 1997-08-29 2000-04-25 Selective Genetics, Inc. Receptor-mediated gene delivery using bacteriophage vectors
EP0999284A1 (en) * 1998-09-11 2000-05-10 Hoechst Marion Roussel Method for screening antimycotic substances using essential genes from c.albicans, and said genes
EP1293564A4 (en) * 2000-06-08 2005-08-17 Mitsubishi Pharma Corp EXPRESSION VECTOR FOR SCREENING CELLS HIGH EXPRESSION OF RECOMBINANT PROTEINS, TRANSFORMING HIGH EXPRESSION OF A RECOMBINANT PROTEIN AND USE THEREOF
US6551828B1 (en) 2000-06-28 2003-04-22 Protemation, Inc. Compositions and methods for generating expression vectors through site-specific recombination
JP4024525B2 (ja) * 2001-11-21 2007-12-19 独立行政法人科学技術振興機構 異なる２つの選択マーカーからなる融合タンパク質
AU2003212708A1 (en) * 2002-03-05 2003-09-16 Stichting Voor De Technische Wetenschappen Baculovirus expression system
IL164687A0 (en) * 2002-05-02 2005-12-18 Univ North Carolina Cellular libraries and methods for the preparationthereof
WO2004033646A2 (en) * 2002-10-04 2004-04-22 E.I. Du Pont De Nemours And Company Process for the biological production of 1,3-propanediol with high yield
EP2133428A1 (en) * 2004-03-09 2009-12-16 Eidgenössische Technische Hochschule Zürich New baculovirus vectors for improved protein production
FR2877013A1 (fr) * 2004-10-27 2006-04-28 Assist Publ Hopitaux De Paris Indentification d'une mutation de jak2 impliquee dans la polyglobulie de vaquez
EP1783228A1 (en) * 2005-11-08 2007-05-09 ETH Zürich Recombinant expression of multiprotein complexes using polygenes
GB0605265D0 (en) * 2006-03-15 2006-04-26 London School Hygiene & Tropical Medicine Virus-like particles of rift valley fever virus
GB0820631D0 (en) 2008-11-11 2008-12-17 London School Hygiene & Tropical Medicine Vectors

Also Published As

Publication number Publication date
US20160090575A1 (en) 2016-03-31
US20110281261A1 (en) 2011-11-17
WO2010055292A2 (en) 2010-05-20
ZA201203945B (en) 2013-01-31
KR20110089420A (ko) 2011-08-08
CO6420360A2 (es) 2012-04-16
CN102245777B (zh) 2016-05-11
CN105400818A (zh) 2016-03-16
CA2740714A1 (en) 2010-05-20
US9212374B2 (en) 2015-12-15
RU2014145441A (ru) 2015-06-20
RU2011114814A (ru) 2012-12-20
CN102245777A (zh) 2011-11-16
UA106733C2 (uk) 2014-10-10
JP2012508004A (ja) 2012-04-05
AU2009315471B2 (en) 2014-07-10
RU2569183C2 (ru) 2015-11-20
PH12014501252A1 (en) 2015-10-05
MX2011004902A (es) 2011-06-16
EP2358883B1 (en) 2016-12-07
SG10201509570TA (en) 2015-12-30
ZA201103286B (en) 2012-10-31
CL2011001056A1 (es) 2011-10-14
MY178947A (en) 2020-10-23
JP5986381B2 (ja) 2016-09-06
EP2358883A2 (en) 2011-08-24
GB0820631D0 (en) 2008-12-17
ES2616855T3 (es) 2017-06-14
WO2010055292A3 (en) 2010-08-26
MX340956B (es) 2016-07-29
US9777260B2 (en) 2017-10-03
AU2009315471A1 (en) 2010-05-20
CL2015000113A1 (es) 2015-06-19
JP2016101164A (ja) 2016-06-02

Similar Documents

Publication Publication Date Title
BRPI0921907A2 (pt) Vetor de transferência para inserir um gene em um local genético de uma seqüência de baculovírus, métodos para produzir um bacmid recombinante, um baculovírus recombinante, e, uma ou mais proteínas, bacmid recombinante, baculovírus recombinante, e, célula.
BR112012006326A2 (pt) anticorpo biespecífico, composição farmacêutica, sequência de ácidos nucleicos, vetor de expressão, célula hospedeira procariótica ou eucariótica e invenção
BR112012024287A2 (pt) anticorpo, composição farmacêutica, método, ácido nucleico, vetor de expressão e célula hospedeira
BRPI0905076A2 (pt) Polipeptídeo, anticorpo, região variável, cadeia pesada ou cadeia leve, gene, vetor, célula hospedeira, método para produzir o referido polipeptídeo, e composição farmacêutica compreendendo o mesmo
BRPI0819509A2 (pt) MICROORGANISMO E VETOR RECOMBINANTE, SACAROSE FOSFOTRANSFERASE, GENE (ptsG), BETA-FRUTOFURANOSIDASE E MÉTODO PARA PRODUZIR METABÓLITOCOS, POLÍMEROS BIODEGRADÁVEIS OU PROTEÍNAS RECOMBINANTES
BRPI0813242A2 (pt) Proteína de ligação a antígeno isolada, ácido nucléico isolado, vetor, célula hospedeira isolada, método para a produção de uma proteína de ligação a antígeno, e, composição.
BRPI0814459A2 (pt) Célula de inseto, método para produzir um vírion parvoviral recombinante em uma célula de inserto, e, construção de ácido nucleico.
BR112012022046A2 (pt) ''anticorpo,composição farmacêutica,ácido nucleico ,vetores de expressão,célula hospedeira e método para a produção de um anticorpo recombinante''.
BRPI0906241A2 (pt) Molécula de ácido nucléico isolada, gene quimérico, vetor e método de transformação de uma célula bacteriana.
BR112013033350A2 (pt) imunocitocina, ácido nucleico, vetor, célula hospedeira e composição farmacêutica
LTC2059534I2 (lt) Genų inžinerijos būdu pagaminti anti-IL-23P19 antikūnai
BRPI0820647A2 (pt) Polipeptídeo isolado, polinucleotídeo isolado, construção de ácido nucleico, célula hospedeira recombinante, métodos para produzir o polipeptídeo e um mutante de uma célula percursora, célula mutante, planta transgênica, parte de planta ou célula de planta, molécula de rna inibidora de filamento duplo, e, métodos para inibir a expressão de um polipeptídeo um uma célula e para produzir uma proteína e para degradar um xilano
BRPI0810357A2 (pt) Método para aumentar a secreção de uma poi a partir de uma célula eucariótica, uso de uma sequência de nucleotídeo, sequência de nucleotídeo, sequência promotora de levedura, vetor de expressão eucariótico, e, usos de um vetor de expressão e de uma sequência promotora de levedura.
BRPI0916964A2 (pt) polipetídeo, anticorpo, ácido nucléico, vetor, célula hospedeira, método para produzir um polipeptídeo, composição e uso do polipeptídeo
BRPI1006368A2 (pt) proteína de fusão. molécula de ácido nucleico, vetor, célula modificada geneticamente, método para produção da proteína de fusão, usos da proteína de fusão, composição, método para preparação de uma composição, kits, método e uso da proteína de fusão
BRPI0819526A2 (pt) "fragmento de ácido nucléico isolado, construção recombinante, célula de planta e método para reduzir a expressão de uma sequência alvo"
BRPI0819495A2 (pt) "fragmento de ácido nucleico isolado, construção recombinante, célula de planta e método para reduzir a expressão de uma sequência alvo"
BRPI1007005A2 (pt) anticorpo isolado , ácido nucleico isolado n vetor, célula isolada , linhagem de célula isolada , composição farmacêutica, e, uso de um anticorpo anti-il-6
BRPI0717768A2 (pt) Anticorpo, epítipo, seqüência de dna isolada, vetor de clonagem ou expressão, célula hospedeira, processo para a produção do anticorpo, composição farmacêutica, e, uso de um anticorpo
BR112012003386A2 (pt) método para comunicação com um nó correspondente, e, nó hospedeiro.
BRPI1006134A2 (pt) anticorpo ou um fragmento funcional do anticorpo, composição farmacêutica, uso de um anticorpo ou um fragmento funcional do mesmo, polinucleotídeo, vetor, e, célula hospedeira transformada.
BRPI1010873A2 (pt) vetor genético
DK3287525T3 (da) RNA-præparater omfattende oprenset modificeret RNA til omprogrammering af celler
BR112013018311A2 (pt) sequência de ácido nucleico isolada, receptor de antígeno quimérico isolado, célula t geneticamente modificada, vetor, e, uso de uma célula t geneticamente modificada.
BRPI1013484A2 (pt) "protease, dna, vetor de expressão , célula transformada, e, método para produzir uma protease".

Legal Events

Date Code Title Description
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]